Top Pre-Market Analyst Downgrades (AMLN, BIIB, CIEN, XOM, GFA, MXIM, BTU, SLT, SPWRA)
These are some of the top pre-market downgrades and cautious calls we have seen from Wall Street analysts this Wednesday morning: Amylin Pharmaceuticals (AMLN) Cut to Sell at Canaccord Adams. Biogen Idec (BIIB) Started as Sell at Brean Murray. Ciena…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
These are some of the top pre-market downgrades and cautious calls we have seen from Wall Street analysts this Wednesday morning:
- Amylin Pharmaceuticals (AMLN) Cut to Sell at Canaccord Adams.
- Biogen Idec (BIIB) Started as Sell at Brean Murray.
- Ciena (CIEN) Cut to Underperform at Credit Suisse.
- Exxon Mobil (XOM) Cut to Neutral at UBS.
- Gafisa (GFA) Cut to Neutral at UBS.
- Maxim Integrated (MXIM) Cut to Equal Weight at Barclays.
- Peabody Energy (BTU) Cut to Market Perform at FBR.
- Sterlite Industries (SLT) Cut to Sell at Citigroup.
- Sunpower (SPWRA) Cut to Accumulate at ThinkEquity.
Jon C. Ogg
January 28, 2009
Contact [email protected] for any questions or corrections.